Literature DB >> 29243195

Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.

Jeung Hui Pyo1, Hyuk Lee2, Yang Won Min3, Byung-Hoon Min3, Jun Haeng Lee3, Kyoung-Mee Kim4, Heejin Yoo5, Soohyun Ahn5, Jae J Kim3.   

Abstract

BACKGROUND: Because of the poor prognosis of proximal gastric cancers, there is debate as to whether the conventional indications for endoscopic resection can be used.
METHODS: Among subjects who underwent surgery for esophagogastric junction or gastric cardia cancer, 256 patients with T1 type II/III of the Siewert classification were included in this study. The association of lymph node metastasis (LNM) with each variable was analyzed using logistic regression models. A receiver operating characteristic curve was used to determine the discriminatory ability of the model. Propensity score-matched non-cardia cancer patients were selected to compare LNM and long-term survival rates.
RESULTS: Of the 256 patients with T1 Siewert II/III gastric cancer, 21 (8.2%) had LNM. Because there was no LNM in T1a cancers, risk factors were analyzed only in patients with T1b. Tumor size (OR 1.42, 95% CI 1.10-1.82, P = 0.007) and lymphovascular invasion (LVI) (OR 5.13, 95% CI 1.88-14.06, P = 0.002) were determined to be predictors of LNM (sensitivity = 66.7% and specificity = 81.6%). Among patients without LVI, the groups with negligible risk for LNM were mucosa-confined cancer, or SM1 cancer with a tumor size ≤3 cm. No LNM was observed in patients satisfying the absolute or extended criteria for endoscopic resection of early gastric cancers. LNM and long-term survival rates of patients with Siewert II/III did not differ significantly compared with matched non-cardia cancer patients.
CONCLUSIONS: Tumor size and LVI were associated with LNM in patients with early Siewert type II/III gastric cancer, and the expanded indication for endoscopic resection may be used.

Entities:  

Keywords:  Early gastric cancer; Endoscopic resection; Lymph node metastasis; Siewert type II/III

Mesh:

Year:  2017        PMID: 29243195     DOI: 10.1007/s10120-017-0789-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  24 in total

Review 1.  Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review.

Authors:  Cecilie Okholm; Lars Bo Svendsen; Michael P Achiam
Journal:  Surg Oncol       Date:  2014-06-11       Impact factor: 3.279

Review 2.  Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies.

Authors:  Fausto Petrelli; Michele Ghidini; Sandro Barni; Francesca Steccanella; Giovanni Sgroi; Rodolfo Passalacqua; Gianluca Tomasello
Journal:  Ann Surg Oncol       Date:  2017-03-15       Impact factor: 5.344

3.  Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  Hiroaki Saito; Youji Fukumoto; Tomohiro Osaki; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

4.  Prognostic predictors of patients with carcinoma of the gastric cardia.

Authors:  Ming Zhang; Zhigao Li; Yan Ma; Guanyu Zhu; Hongfeng Zhang; Yingwei Xue
Journal:  Hepatogastroenterology       Date:  2012-05

5.  Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for esophagogastric junction adenocarcinoma.

Authors:  Eun Jeong Gong; Do Hoon Kim; Ji Yong Ahn; Kee Wook Jung; Jeong Hoon Lee; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Hee Sung Kim; In-Seob Lee; Beom Su Kim; Moon-Won Yoo; Sung Tae Oh; Jeong Hwan Yook; Byung Sik Kim
Journal:  Gastric Cancer       Date:  2016-12-19       Impact factor: 7.370

6.  Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.

Authors:  Hiroharu Yamashita; Hitoshi Katai; Shinji Morita; Makoto Saka; Hirokazu Taniguchi; Takeo Fukagawa
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

7.  Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer.

Authors:  Masami Omae; Junko Fujisaki; Yusuke Horiuchi; Natsuko Yoshizawa; Yasumasa Matsuo; Manabu Kubota; Takanori Suganuma; Kazuhisa Okada; Akiyoshi Ishiyama; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Etsuo Hoshino; Masahiro Igarashi
Journal:  Gastric Cancer       Date:  2012-06-13       Impact factor: 7.370

8.  Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia.

Authors:  Kenneth E L McColl; James J Going
Journal:  Gut       Date:  2010-03       Impact factor: 23.059

9.  Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction.

Authors:  Masayoshi Yamada; Ichiro Oda; Satoru Nonaka; Haruhisha Suzuki; Shigetaka Yoshinaga; Hirokazu Taniguchi; Shigeki Sekine; Ryoji Kushima; Yutaka Saito; Takuji Gotoda
Journal:  Endoscopy       Date:  2013-11-28       Impact factor: 10.093

10.  The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.

Authors:  Hironobu Goto; Masanori Tokunaga; Yuichiro Miki; Rie Makuuchi; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2014-03-22       Impact factor: 7.370

View more
  4 in total

1.  Comparing long-term outcomes between endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for type II esophagogastric junction neoplasm.

Authors:  Yong Liu; Shun He; Yueming Zhang; Lizhou Dou; Xiao Liu; Xinying Yu; Ning Lu; Liyan Xue; Guiqi Wang
Journal:  Ann Transl Med       Date:  2021-02

2.  Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma.

Authors:  Hui Wang; Yao Peng; Qi Huang; Jingjing Wu; Mingjun Zhang
Journal:  Biomed Res Int       Date:  2021-03-24       Impact factor: 3.411

3.  Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery.

Authors:  Chengbin Zheng; Xingyu Feng; Jiabin Zheng; Qian Yan; Xu Hu; Huolun Feng; Zhenru Deng; Qianchao Liao; Junjiang Wang; Yong Li
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

4.  Endoscopic Versus Surgical Therapy for Early Esophagogastric Junction Adenocarcinoma Based on Lymph Node Metastasis Risk: A Population-Based Analysis.

Authors:  Hua Ye; Ping Chen; Yi-Fan Wang; Xiu-Jun Cai
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.